【结 构 式】 |
【分子编号】14747 【品名】(4R)-6-[[2-(2-aminoethoxy)ethoxy]methyl]-4-(2,3-dichlorophenyl)-5-(ethoxycarbonyl)-2-methyl-1,4-dihydro-3-pyridinecarboxylic acid 【CA登记号】 |
【 分 子 式 】C21H26Cl2N2O6 【 分 子 量 】473.35272 【元素组成】C 53.29% H 5.54% Cl 14.98% N 5.92% O 20.28% |
合成路线1
该中间体在本合成路线中的序号:(V)A synthesis of S-12968 has been published: The cyclization of 4-[2-(2-phthalimidoethoxy)ethoxy]-3-oxobutyric acid ethyl ester (I) with 2-(2,3-dichlorobenzylidene)-3-oxobutyric acid 2-cyanoethyl ester (II) and ammonium formate in hot ethanol gives the protected racemic 1,4-dihydropyridine (III), which is submitted to a chiral preparative HPLC to obtain the (R)-(-)-enantiomer (IV). The deprotection of (IV) with aqueous methylamine affords (S)-(-)-2-[2-(2-aminoethoxy)ethoxymethyl]-4-(2,3-dichlorophenyl)-1,4-di hydropyridine-3,5-dicarboxylic acid 3-monoethyl ester (V). Finally, this compound is methylated with diazomethane in ethyl ether/methanol. The starting compound, the dichlorobenzylidene derivative (II) has been obtained as follows: The condensation of Meldrum's acid (X) with acetic acid (XII) by means of CDI and pyridine as before gives 5-acetyl-2,2-dimethyl-1,3-dioxane-4,6-dione (XIII), which is submitted to ring opening with 3-hydroxypropionitrile (XIV) in refluxing toluene yielding 2-cyanoethyl acetoacetate (XV). Finally, the condensation of (XV) with 2,3-dichlorobenzaldehyde (XVI) by means of piperidine and hexanoic acid in refluxing benzene affords the dichlorobenzylidene derivative (II) used as the second starting compound.
【1】 Dolle, F.; et al.; Highly efficient synthesis of [11C]S12968 and [11C]S12967, for the in vivo imaging of the cardiac calcium channels using PET. J Label Compd Radiopharm 2001, 44, 7, 481. |
【2】 Crouzel, C.; Duval, R.; Hinnen, F.; Fuseau, C.; Dollé, F.; Valette, H.; Péglion, J.-L.; Synthesis of two optically active calcium channel antagonists labelled with carbon-11 for in vivo cardiac PET imaging. Bioorg Med Chem 1997, 5, 4, 749. |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 14743 | ethyl 4-[2-[2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)ethoxy]ethoxy]-3-oxobutanoate | C18H21NO7 | 详情 | 详情 | |
(II) | 14744 | 2-cyanoethyl (Z)-2-acetyl-3-(2,3-dichlorophenyl)-2-propenoate | C14H11Cl2NO3 | 详情 | 详情 | |
(III) | 14745 | 5-(2-cyanoethyl) 3-ethyl 4-(2,3-dichlorophenyl)-2-([2-[2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)ethoxy]ethoxy]methyl)-6-methyl-1,4-dihydro-3,5-pyridinedicarboxylate | C32H31Cl2N3O8 | 详情 | 详情 | |
(IV) | 14746 | 5-(2-cyanoethyl) 3-ethyl (4S)-4-(2,3-dichlorophenyl)-2-([2-[2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)ethoxy]ethoxy]methyl)-6-methyl-1,4-dihydro-3,5-pyridinedicarboxylate | C32H31Cl2N3O8 | 详情 | 详情 | |
(V) | 14747 | (4R)-6-[[2-(2-aminoethoxy)ethoxy]methyl]-4-(2,3-dichlorophenyl)-5-(ethoxycarbonyl)-2-methyl-1,4-dihydro-3-pyridinecarboxylic acid | C21H26Cl2N2O6 | 详情 | 详情 | |
(X) | 14738 | Meldrum's acid; 2,2-dimethyl-1,3-dioxane-4,6-dione;Malonic acid cyclic isopropylidene ester | 2033-24-1 | C6H8O4 | 详情 | 详情 |
(XIII) | 12273 | 5-Acetyl-2,2-dimethyl-1,3-dioxane-4,6-dione | C8H10O5 | 详情 | 详情 | |
(XIV) | 14029 | Ethylene cyanohydrin; ECN; 3-Hydroxypropanenitrile | 109-78-4 | C3H5NO | 详情 | 详情 |
(XV) | 13993 | 2-cyanoethyl 3-oxobutanoate | C7H9NO3 | 详情 | 详情 | |
(XVI) | 14742 | 2,3-dichlorobenzaldehyde | 6334-18-5 | C7H4Cl2O | 详情 | 详情 |
合成路线2
该中间体在本合成路线中的序号:(V)This compound has been obtained by three related ways: 1. Dihydropyridine amino acid (V) is methylated with (11C-labeled)-diazomethane (VI) in ethyl ether/methanol to afford the target compound. 2. The methylation of the dihydropyridine amino acid (V) can also be performed with (11C-labeled)-methyl iodide (VII) and trimethylbenzylammonium hydroxide in DMF/EtOH. 3. The preceding methylation can also been performed with (11C-labeled)-methyl triflate (VIII) and trimethylbenzylammonium hydroxide in DMF/EtOH. The (11C-labeled)-diazomethane (VI), (11C-labeled)-methyl iodide (VII) and (11C-labeled)-methyl triflate (VIII) have been obtained as follows: a. The chlorination of (11C-labeled)-methane (IX) with chlorine and CuCl2 at 330 C gives labeled chloroform (X), which is then treated with hydrazine and KOH in ethanol to yield the desired (11C-labeled)-diazomethane (VI). b. The reduction of (11C-labeled)-CO2 (XI) with LiAlH4 in THF gives (11C-labeled)-methanol (XII), which is treated with 57% IH to yield the desired (11C-labeled) methyl iodide (VII). c. Finally, the reaction of (11C-labeled)-methyl iodide (VII) with silver triflate affords the desired (11C-labeled)-methyl triflate (VIII).
【1】 Dolle, F.; et al.; Highly efficient synthesis of [11C]S12968 and [11C]S12967, for the in vivo imaging of the cardiac calcium channels using PET. J Label Compd Radiopharm 2001, 44, 7, 481. |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(V) | 14747 | (4R)-6-[[2-(2-aminoethoxy)ethoxy]methyl]-4-(2,3-dichlorophenyl)-5-(ethoxycarbonyl)-2-methyl-1,4-dihydro-3-pyridinecarboxylic acid | C21H26Cl2N2O6 | 详情 | 详情 |